title: Paraoxonase polymorphisms, haplotypes, and enzyme activity in Latino mothers and newborns.
abstract: Recent studies have demonstrated widespread pesticide exposures in pregnant women and in children. Plasma paraoxonase 1 (PON1) plays an important role in detoxification of various organophosphates. The goals of this study were to examine in the Center for Health Assessment of Mothers and Children of Salinas (CHAMACOS) birth cohort of Latina mothers and their newborns living in the Salinas Valley, California, the frequencies of five PON1 polymorphisms in the coding region (192QR and 55LM) and the promoter region (-162AG, -909CG, and -108CT) and to determine their associations with PON1 plasma levels [phenylacetate arylesterase (AREase) ] and enzyme activities of paraoxonase (POase) and chlorpyrifos oxonase (CPOase) . Additionally, we report results of PON1 linkage analysis and estimate the predictive value of haplotypes for PON1 plasma levels. We found that PON1-909, PON1-108, and PON1(192) had an equal frequency (0.5) of both alleles, whereas PON1-162 and PON1(55) had lower variant allele frequencies (0.2) . Nearly complete linkage disequilibrium was observed among coding and promoter polymorphisms (p < 0.001) , except PON1(192) and PON1-162 (p > 0.4) . Children's PON1 plasma levels (AREase ranged from 4.3 to 110.7 U/mL) were 4-fold lower than their mothers' (19.8 to 281.4 U/mL) . POase and CPOase activities were approximately 3-fold lower in newborns than in mothers. The genetic contribution to PON1 enzyme variability was higher in newborns (R2 = 25.1% by genotype and 26.3% by haplotype) than in mothers (R2 = 8.1 and 8.8%, respectively) . However, haplotypes and genotypes were comparable in predicting PON1 plasma levels in mothers and newborns. Most of the newborn children and some pregnant women in this Latino cohort may have elevated susceptibility to organophosphate toxicity because of their PON1192 genotype and low PON1 plasma levels.
authors.affiliation: Center for Children's Environmental Health, School of Public Health, University of California, Berkeley, California, USA. ninah@berkely.edu
authors.forename: Nina
authors.initials: N
authors.lastname: Holland
authors.forename: Clement
authors.initials: C
authors.lastname: Furlong
authors.forename: Maria
authors.initials: M
authors.lastname: Bastaki
authors.forename: Rebecca
authors.initials: R
authors.lastname: Richter
authors.forename: Asa
authors.initials: A
authors.lastname: Bradman
authors.forename: Karen
authors.initials: K
authors.lastname: Huen
authors.forename: Kenneth
authors.initials: K
authors.lastname: Beckman
authors.forename: Brenda
authors.initials: B
authors.lastname: Eskenazi
mesh_terms: D000293:Adolescent; D000328:Adult; D043303:Aryldialkylphosphatase / Q000235:genetics*; D005260:Female; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D007843:Latin America; D009035:Mothers; D010641:Phenotype; D011110:Polymorphism, Genetic / Q000235:genetics*; D011247:Pregnancy
chemical_list: D043303:Aryldialkylphosphatase